2022
DOI: 10.1016/j.dhjo.2021.101259
|View full text |Cite
|
Sign up to set email alerts
|

Birth outcomes among women with congenital neuromuscular disabilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Additionally, we applied a weight variable to the data set to represent the approximate 3% national prevalence of major congenital anomalies. This reweighting approach is explained in further detail elsewhere (Huezo García et al, 2021; Richardson, Rzehak, Klenk, & Weiland, 2007). We present unweighted and weighted estimates for all analyses in supplemental tables (see Appendix).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, we applied a weight variable to the data set to represent the approximate 3% national prevalence of major congenital anomalies. This reweighting approach is explained in further detail elsewhere (Huezo García et al, 2021; Richardson, Rzehak, Klenk, & Weiland, 2007). We present unweighted and weighted estimates for all analyses in supplemental tables (see Appendix).…”
Section: Methodsmentioning
confidence: 99%
“…Medication during pregnancy can be critical in maintaining the mother's health, but may lead to certain pregnancy complications. Understanding the prevalence of medication use during pregnancy among women with congenital physical disabilities is important to better recognize their specific health needs that may warrant clinical treatment, as well as assessing the cause of the increased risk of pregnancy complications common in this population (Huezo García, Parker, Petersen, Rubenstein, & Werler, 2021; Tarasoff, Ravindran, et al, 2020).…”
Section: Introductionmentioning
confidence: 99%